RUNX3 and colorectal cancer: Knowing that RUNX3 represses TBC1D7, our observation appears to pinpoint RUNX3 to reciprocal control of the Wnt/β-catenin and PI3K/AKT/mTORC1 pathways, inter alia involved in the failure of colorectal cancer treatment [47].